These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Molecular bases of cancer immunology]. Barrera-Rodríguez R; Peralta-Zaragoza O; Madrid-Marina V Salud Publica Mex; 1995; 37(4):344-53. PubMed ID: 7502157 [TBL] [Abstract][Full Text] [Related]
10. High frequency of alloreactive T cells is a consequence of the presentation of many peptides by allogeneic MHC molecules. Salom R; Brookes P; Hornick P; Lechler R Transplant Proc; 1995 Dec; 27(6):3579. PubMed ID: 8540111 [No Abstract] [Full Text] [Related]
11. T-cell allorecognition: a case of mistaken identity or déjà vu? Archbold JK; Macdonald WA; Burrows SR; Rossjohn J; McCluskey J Trends Immunol; 2008 May; 29(5):220-6. PubMed ID: 18378495 [TBL] [Abstract][Full Text] [Related]
12. Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras. Onoé K; Gotohda T; Nishihori H; Aranami T; Iwabuchi C; Iclozan C; Morohashi T; Ogasawara K; Good RA; Iwabuchi K Transpl Immunol; 2003; 12(1):79-88. PubMed ID: 14551035 [TBL] [Abstract][Full Text] [Related]
13. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy. Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition. Sitaru AG; Timmermann W; Ulrichs K; Otto C Hum Immunol; 2004 Aug; 65(8):817-25. PubMed ID: 15336783 [TBL] [Abstract][Full Text] [Related]
16. [Regulation of the immune response by HLA molecules]. Sterkers G; Zeliszewski D; Eljaafari-Corbin A Ann Rech Vet; 1992; 23(3):265-8. PubMed ID: 1416733 [No Abstract] [Full Text] [Related]